Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
enzymology [2023/10/30 06:57] – quality_manager | enzymology [2025/02/09 10:31] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | 1. Enzymes do not affect equilibrium of chemical reaction. | + | - Enzymes do not affect equilibrium of chemical reaction. |
- | + | | |
- | 2. Km and Vmax in competitive and noncompetitive enzyme inhibition | + | |
- | + | | |
- | 3. Catalytic constant and catalytic efficiency | + | - Explain different types of isoenzymes and isoforms of Creatine Kinase in humans. Describe principle of measurement of CK-MB by catalytic method and mass method. Why the catalytic method generally contain N-acetyl cysteine, AMP and diadenosine-pentaphosphate |
- | + | - Single molecule enzymology | |
- | 4. Difference between feedback regulation and feedback inhibition | + | |
- | + | - Describe biochemical mechanism of action of antibiotics affecting bacterial cell wall. Explain biochemical strategies used by bacteria to develop resistance to these antibiotics. | |
- | + | - Explain mechanism of autoimmune disease following bacterial infection and immune-mediated hypersensitivity to antibiotics | |
- | + | | |
- | + | | |
- | Describe biochemical structure of bacterial cell wall and give overview of its synthesis. How does it differ in Gram positive and negative organisms. Describe biochemical mechanism of action of antibiotics affecting bacterial cell wall. Explain biochemical strategies used by bacteria to develop resistance to these antibiotics. Explain mechanism of autoimmune disease following bacterial infection and immune-mediated hypersensitivity to antibiotics | + | |
- | + | | |
- | 11. Single molecule enzymology | + | |
- | 12. Molar absorptivity of NADH and calculation of enzyme factors | + | |
- | 13. Recombinant fusion proteins in affinity chromatography purification of proteins | + | |
- | 14. artifacts from RNA world | + | |
- | 19. Compare and contrast five Basic Local Alignment Search Tools (BLAST) | + | |
- | 20. Cytochrome P-450 | + | |
- | 22. States of respiratory control | + | -Group 1 and group 2 hormones |
- | 26. | + | |
- | 28. Overview of amino acid metabolism | + | |
- | 98. Membrane asymmetry | + | |
- | 99. specialized plasma membranes | + | |
- | 100. Structure of K+ channel and selectivity | + | |
- | 101. Structure and function of clathrin coated vesicles | + | -Sources of free radicals and tissue damages caused by them |
- | 102. Group 1 and group 2 hormones | + | -Antioxidents can be pro-oxidents |
- | 105. Regulation of gene expression by class 1 hormones | + | |
- | 106. G protein coupled receptors | + | |
- | 107. Phospholipase C mediated second messenger system | + | |
- | 108. Insulin signaling - | + | |
- | 109. Nuclear receptor superfamily | + | |
- | 115. Sources of free radicals and tissue damages caused by them | + | |
- | 116. Antioxidents can be pro-oxidents | + | |
- | 124. COP 1, COP2 and clathrin coated vesicles | + | |
- | 125. Lectins | + | |
- | 126. Role of dolichol in synthesis of N-linked glycoprotein | + | |
- | 127. GPI anchored proteind | + | |
- | 131. Biochemical mechanism of bone resorption in ostoclast | + | |
- | 132. Molecular organization in cartilages | + | |
- | 133. | + | |
- | 138. Metabolism and function of nitrogen oxide | + | |
- | 139. | + | -Various types of type-2 reactions in metabolism of xenobiotics |
- | 140. | + | |
- | 145. alpha-1 antitrypsin function and deficiency | + | |
- | 146. genetics of ABO blood groups | + | |
- | 147. Metabolism of RBC | + | |
- | 148. Important reactions related to oxidative stress in various cells | + | |
- | 149. RBC cytoskeleton and hereditary spherocytosis | + | |
- | 150. Respiratory burst in neutrophils and related disorders | + | |
- | 151. Role of NADPH oxidase and myeloperoxidase in neutrophils | + | -Biochemical basis of apoptosis |
- | 152. Properties of cytochrome P450 | + | |
- | 153. Various types of type-2 reactions in metabolism of xenobiotics | + | |
- | 154. Xenobiotic mediated cell inury | + | |
- | 155. Mitochondrial theory of aging | + | |
- | 156. Role of protein glycation in protein-protein crosslinking | + | |
- | 157. Metabolic theory of aging | + | |
- | 158. Telomere – structure, function and its replication | + | |
- | 159. Ames test for detection of carcinogens | + | -Various types of blood collection tubes for serum separation |
- | 160. Oncogenes | + | |
- | 161. Biochemical basis of apoptosis | + | |
- | 162. Biochemical aspects of metastasis | + | |
- | 163. | + | -Biochemical basis of expected results of various laboratory examination in renal tubular acidosis |
- | 164. Hypoxia induced molecular events leading to altered gene expression | + | -Capillary blood sampling – methods and uses |
- | 165. Explain leuminescence, | + | |
- | 166. Dietary reference intake | + | |
- | 167. Shotgun sequencing | + | |
- | 168. Ethics in medical laboratory | + | -Limitations of use of SI units in clinical chemistry |
- | 169. Principle of electrochemileuminesence | + | -Blunt end recombination of DNA |
- | 170. Cost minimization, | + | -Describe detailed process map of blood sample centrifugation. Identify risks involved in the process and possible steps to mitigate them. |
- | 171. Various types of blood collection tubes for serum separation | + | |
- | 172. Lactic acidosis – causes and biochemical basis of expected results of various laboratory examination | + | |
- | 173. Causes and biochemical basis of expected results of various laboratory examination in diabetic ketoacidosis | + | |
- | 174. Biochemical basis of expected results of Blood gas analysis in severe emphysema | + | |
- | 175. Biochemical basis of expected results of various laboratory examination in renal tubular acidosis | + | |
- | 176. Capillary blood sampling – methods and uses | + | -Current recommendations on use of tumor markers |
- | 177. Types questions clinicians try to answer by requesting laboratory examinations | + | |
- | 178. Voltametry in clinical chemistry | + | -Screening for urine microalbuminuria in diabetes mellitus |
- | 179. Types of bilirubin in plasma and its detection by various methods | + | |
- | 180. Limitations of use of SI units in clinical chemistry | + | |
- | 181. Blunt end recombination of DNA | + | |
- | 22. Describe detailed process map of blood sample centrifugation. Identify risks involved in the process and possible steps to mitigate them. | + | |
- | + | ||
- | Clinical Chemistry | + | |
- | 1. Ethical issues in clinical chemistry | + | |
- | 2. | + | |
- | 63. | + | |
- | 156. **Principles, advantages, | + | |
- | 157. Describe genetics, clinical significance, | + | |
- | 158. Current applications of tumor markers and their limitations | + | |
- | 159. Current recommendations on use of tumor markers | + | |
- | 160. Enzymes as tumor markers | + | |
- | 161. Screening for urine microalbuminuria in diabetes mellitus | + | |
- | 162. Describe formation of creatinine in body Describe salient features of chemical and enzymatic methods for serum creatinine measurement. Give account of quality issues in creatinine measurement. List advantages and disadvantages of markers of GFR. Explain use of IDMS traceable MDRD equation for estimating GFR from serum creatinine. | + | |
- | 166. | + | |
- | 167. Explain different types of isoenzymes and isoforms of Creatine Kinase in humans. Describe principle of measurement of CK-MB by catalytic method and mass method. Why the catalytic method generally contain N-acetyl cysteine, AMP and diadenosine-pentaphosphate | + | |